Last reviewed · How we verify

Control group (diosmin) — Competitive Intelligence Brief

Control group (diosmin) (Control group (diosmin)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Flavonoid/Venoactive agent. Area: Cardiovascular.

phase 3 Flavonoid/Venoactive agent Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Control group (diosmin) (Control group (diosmin)) — Hanoi Medical University. Diosmin is a flavonoid that improves venous tone and reduces capillary permeability to enhance microcirculation and lymphatic drainage.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Control group (diosmin) TARGET Control group (diosmin) Hanoi Medical University phase 3 Flavonoid/Venoactive agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Flavonoid/Venoactive agent class)

  1. Hanoi Medical University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Control group (diosmin) — Competitive Intelligence Brief. https://druglandscape.com/ci/control-group-diosmin. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: